mRNA vaccines: Why and how they should be modified
Open Access
- 11 October 2021
- journal article
- letter
- Published by PAGEPress Publications in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
- Vol. 94 (2)
- https://doi.org/10.4081/jbr.2021.10072
Abstract
Dear editor, The COVID-19 pandemic has stimulated the production of different therapeutic approaches for the resolution of coronavirus infections. On one hand, nanobiomolecules have been proposed as bait material for viruses, 1 on the other hand unconventional messenger RNA vaccines have been produced like SARS-CoV-2 mRNA vaccines (BioNTech / Pfizer BNT162b2 and Moderna mRNA-1273).Keywords
This publication has 31 references indexed in Scilit:
- Nucleoside Modified mRNA Vaccines for Infectious DiseasesPublished by Springer Science and Business Media LLC ,2016
- A 3′ Poly(A) Tract Is Required for LINE-1 RetrotranspositionMolecular Cell, 2015
- N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and miceJournal of Controlled Release, 2015
- Primate-Specific ORF0 Contributes to Retrotransposon-Mediated DiversityCell, 2015
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapyExpert Opinion on Biological Therapy, 2015
- Processed pseudogenes acquired somatically during cancer developmentNature Communications, 2014
- Diversity through duplication: Whole‐genome sequencing reveals novel gene retrocopies in the human populationBioEssays, 2014
- LINE-1 Retrotransposable Element DNA Accumulates in HIV-1-Infected CellsJournal of Virology, 2013
- Somatic retrotransposition alters the genetic landscape of the human brainNature, 2011
- Finishing the euchromatic sequence of the human genomeNature, 2004